Serological follow-up in patients with aorto-iliac disease and evidence of Q fever infection
- 12 March 2014
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 33 (8) , 1407-1414
Abstract
The aim of this study was to provide data on the risk of developing chronic Q fever in patients with aorto-iliac disease and evidence of previous Q fever infection. Patients with an aortic and/or iliac aneurysm or aorto-iliac reconstruction (aorto-iliac disease) and evidence of previous Q fever infection were included. The presence of phase I and II Coxiella burnetii IgG antibodies was assessed periodically using immunofluorescence assay. A total of 111 patients with aorto-iliac disease were divided into three groups, based upon the serological profile [mean follow-up: 16 ± 9 months (mean ± standard deviation)]. Group 1 consisted of 30 patients with a serological trace of C. burnetii infection (negative IgG phase I, IgG phase II titer of 1:32). Of these, 36.7 % converted to serological profile matching past resolved Q fever. Group 2 included 49 patients with negative IgG phase I titer and IgG phase II titer ≥1:64. No patients developed chronic Q fever, but 14.3 % converted to a positive IgG phase I titer. Group 3 consisted of 32 patients with positive IgG phase I and positive IgG phase II titers, of which 9.4 % developed chronic Q fever (significantly different from group 2, p = 0.039). The IgG phase I titer increased in 28.1 % of patients (from 1:64 to 1:4,096). The risk of developing chronic Q fever in patients with aorto-iliac disease and previous Q fever infection with a positive IgG phase I titer was 9.4 %. The IgG phase I titer increases or becomes positive in a substantial number of patients. A standardized serological follow-up is proposed.Keywords
This publication has 26 references indexed in Scilit:
- Strategies for early detection of chronic Q‐fever: a systematic reviewEuropean Journal of Clinical Investigation, 2013
- Prevalence of Chronic Q Fever in Patients with a History of Cardiac Valve Surgery in an Area Where Coxiella burnetii Is EpidemicClinical and Vaccine Immunology, 2012
- Evaluation of Commonly Used Serological Tests for Detection of Coxiella burnetii Antibodies in Well-Defined Acute and Follow-Up SeraClinical and Vaccine Immunology, 2012
- Identification of Risk Factors for Chronic Q Fever, the NetherlandsEmerging Infectious Diseases, 2012
- Microbiological Challenges in the Diagnosis of Chronic Q FeverClinical and Vaccine Immunology, 2012
- Coxiella burnetii infection among blood donors during the 2009 Q‐fever outbreak in the NetherlandsTransfusion, 2011
- Real-Time PCR with Serum Samples Is Indispensable for Early Diagnosis of Acute Q FeverClinical and Vaccine Immunology, 2010
- Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcomeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Role of Sex, Age, Previous Valve Lesion, and Pregnancy in the Clinical Expression and Outcome of Q Fever after a Large OutbreakClinical Infectious Diseases, 2007
- Natural history and pathophysiology of Q feverThe Lancet Infectious Diseases, 2005